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We evaluated the effect of acupuncture on NSAID resistant dysmenorrhea related pain
[measured according to Visual Analogue Scale (VAS)] in 15 consecutive patients. Pain was
measured at baseline (T1), mid treatment (T2), end of treatment (T3) and 3 (T4) and 6 months
(T5) after the end of treatment. Substantial reduction of pain and NSAID assumption was
observed in 13 of 15 patients (87%). Pain intensity was significantly reduced with respect to
baseline (average VAS¼8.5), by 64, 72, 60 or 53% at T2, T3, T4 or T5. Greater reduction of
pain was observed for primary as compared with secondary dysmenorrhea. Average pain
duration at baseline (2.6 days) was significantly reduced by 62, 69, 54 or 54% at T2, T3, T4 or
T5. Average NSAID use was significantly reduced by 63, 74, 58 or 58% at T2, T3, T4 or T5,
respectively, and ceased totally in 7 patients, still asymptomatic 6 months after treatment. Our
findings suggest that acupuncture may be indicated to treat dysmenorrhea related pain, in
particular in those subjects in whom NSAID or oral contraceptives are contraindicated or
refused.
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Introduction
Dysmenorrhea is a common symptom, reported by  25%
of women, and by up to 90% of adolescents (1–4).
It has been reported to impair current working activity
(5,6) in 10% of cases, as well as quality of life (7) and
is the main cause of non-attendance at school for
adolescents (2,3,5,8), and the first cause for adolescents
seeking medical advice (9). Dysmenorrhea is commonly
categorized as ‘primary’, i.e. in absence of proven pelvic
pathology, or ‘secondary’, i.e. in presence of pelvic pathol-
ogy: the distinction has mainly a therapeutic purpose, as
for cases of secondary dysmenorrhea (e.g. endometriosis
or pelvic inflammatory disease) a specific treatment
may be offered (10). Pain is the dominating symptom,
not controlled by NSAID assumption in 20–25% of
cases (11), and several other symptoms, contributing to
the pre-menstrual syndrome, may be associated, reaching
severe intensity in 3.5–5% of cases (12).
Non-conventional medicine has become very popular in
western countries in recent years (13,14). Acupuncture,
a traditional Chinese medicine procedure, is well toler-
ated and free of relevant side effects (15) and has been
approved by FDA (16). Acupuncture is commonly used
to treat chronic pelvic pain (17), and its use has been recently
recommended by the National Institute of Health for the
treatment of several diseases, including dysmenorrhea.
The aim of the present study was to assess the
efficacy of acupuncture in a consecutive series of
women affected by primary or secondary dysmenorrhea
(painful menstrual cramps without or with evident
pathology to account for them), not controlled by
NSAID. Efficacy was measured in terms of pain control,
impact on NSAID consumption, and cost-effectiveness.
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Treated Series Characteristics and Treatment Modalities
Between December 2004 and March 2005, a consecu-
tive series of 15 nulliparous patients (age range 13–35,
average 27) was enrolled at the ‘Mario Tiengo’ Pain
Control Clinic of the Mangiagalli-Regina Elena Hospital
of Milan, Italy. Patients were suffering from moderate
to severe dysmenorrhea since at least 1 year, had a
poor response to NSAID and refused oral contracep-
tive therapy, which is currently employed as a first line
treatment of dysmenorrhea (4,18,19). All patients under-
went careful anamnesis, pain evaluation, transvaginal
ultrasound (transabdominal if virgo), and CA125 dosage
in the second part of menstrual cycle. Patients features at
presentation are summarized in Table 1.
All patients were given 8weekly acupuncture sessions, for
a total duration of 2 months. Needle positioning was based
on conventional diagnostic criteria of traditional Chinese
medicine. Sterile needles were positioned for 30min at
a variety of acupoints, namely KI-3, LV-3, SP-4, ST-36,
ST-25, ST-29, ST-30, REN-4, REN-6, BL-62, HT-7, LI-4,
PC-6 and ZI GONG extra point. (20). No limitation to
additional NSAID use was required, if necessary.
Results Assessment Methodology
The efficacy of acupuncture was assessed through Visual
Analogue Scales (VAS), a self assessment scale ranging
from 0 to 10, where the patient was requested to indicate
the point most representative of pain intensity, from score 0
(no pain) to score 10 (pain as bad as it could be), chosen for
its simplicity (21).VAS was determined at five different
points in time, namely baseline (T1), mid treatment (T2),
end of treatment (T3), and 3 (T4) and 6 months (T5) after
the end of treatment. Overall NSAID use (number of
assumed doses), and duration of pain (days), were
determined at the same points in time. Cost analysis was
attempted, based on average cost of baseline NSAID
(Nimesulide) use (E0.1563/single dose), assumed to be
stable in absence of acupuncture, for a period of 8 months
(equivalent to 2 months of acupuncture treatment
þ6months of follow-up), compared with (i) the cost of
NSAID documented use since treatment started, plus (ii)
the cost of the acupuncture procedure (E17.50 per session,
according to Regional Health Service tariff).
Statistical Analysis
Statistical significance (P50.05) of observed results
was determined by analyzing the distribution of pain
intensity (VAS), pain duration and NSAID consumption
at T1 (prior to treatment) as compared with T3 (end
of treatment) or T5 (6 months after end of treatment)
with Wilcoxon’s signed rank test, using STATA 8.0
(www.stata.com) software.
Results
Treatment Effects on Pain
All patient’s completed treatment and follow-up. Overall
treatment response (substantial reduction of pain and
Table 1. Patients characteristics
Patient Age Menarche Dysmenorrhea Anamnesis US US report Ca-125
1 33 12 Secondary Sterility TV
a Endometrioma
c 89
2 29 13 Primary Negative TV Negative 13
3 35 14 Secondary Hyperthyroidism TV Endometrioma
c 67
Appendicectomy
4 25 12 Secondary Negative TV Endometrioma
c 78
5 27 12 Primary Negative TV Negative 11
6 33 13 Secondary Appendicectomy TV Suspicious adhesive syndrome 36
Lumbar hernia
7 35 14 Secondary Sterility TV Suspicious adenomioma 35
8 25 12 Primary Chronic gastritis TV Negative 10
9 13 10 Primary Appendicectomy TA
b Negative 6
10 27 12 Secondary Nervous anorexia TV Pelvic varicocele 8
11 29 11 Secondary Appendicectomy TV Suspicious adhesive syndrome 7
12 32 14 Primary Negative TV Negative 19
13 35 15 Primary Negative TV Negative 28
14 18 14 Secondary Appendicectomy TV Suspicious adhesive syndrome 6
15 13 11 Primary Negative TA Negative 7
aTV, transvaginal,
bTA, transabdominal,
cconfirmed at laparoscopy.
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(87%). Overall, pain remained unchanged, was only
temporarily reduced, was permanently reduced or
disappeared and did not recur in 2, 3, 3 or 7 patients,
respectively. Detailed data on pain over time are
given in Fig. 1.
Figure 2 shows the average effects of treatment on pain
at different time points: VAS based pain intensity was
reduced with respect to baseline value (average
VAS¼8.5), namely by 64, 72, 60 or 53% at T2, T3,
T4 or T5, respectively. Greater reduction of pain was
observed for primary (82, 88, 66 and 51%) as compared
with secondary dysmenorrhea (47, 57, 56 and 56%). Pain
intensity reduction with respect to T1 was statistically
significant at T3 (P¼0.0008) and at T5 (P¼0.0022).
Figure 3 shows treatment results according to pain
duration (days) at different points in time. Average pain
duration at baseline (2.6 days) was reduced by 62, 69,
54 or 54% at T2, T3, T4 or T5, respectively. Pain
duration with respect to T1 was significantly reduced at
T3 (P¼0.0004) and at T5 (P¼0.0016).
Treatment Effects on NSAID Consumption
NSAID use was recorded in all patients at baseline.
Average NSAID use was reduced by 63, 74, 58 or 58% at
T2, T3, T4 or T5, respectively, and ceased totally in
7 patients, still asymptomatic 6 months after treatment.
Data are summarized in Fig. 4. NSAID average
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Figure 1. Pain response over time. Visual Analogue Scale (VAS) values
in single patients at different points in time (T1¼baseline, T2¼mid
treatment, T3¼end treatment, T4¼3 months after treatment,
T5¼6 months after treatment).
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Figure 3. Results of treatment on average duration (days) of pain, at
different points in time.
Figure 2. Average results of treatment on pain, measured at VAS, at
different points in time and according to dysmenorrhea type (primary
or secondary).
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Figure 4. Total use of anti-pain drugs before, during, and after
acupuncture treatment (T1¼baseline, T2¼mid treatment, T3¼end
treatment, T4¼3 months after treatment, T5¼6 months after
treatment).
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at T3 (P¼0.0008) and at T5 (P¼0.0015).
No side effects of acupuncture were observed or
reported by patients.
Cost Analysis
Although acupuncture substantially reduced NSAID use,
cost analysis showed a higher cost for the acupuncture
policy (E2,148.14) as compared with predicted cost of
NSAID use (E120.03).
Discussion
The present study, though limited to a single treatment
arm, shows a favorable effect of acupuncture in con-
trolling the duration and intensity of moderate/severe
dysmenorrhea related pain (VAS 6) over time, thus
confirming previous reports of non-controlled studies (22)
and of two controlled trials of acupuncture reported thus
far (23,24).
Pain control (minor or absent, VAS 2) obtained
at the end of treatment is maintained up to 6 months
in approximately 50% of cases, which confirms that
acupuncture obtains more than just a temporary sympto-
matic effect. As a placebo effect cannot be excluded, the
observed effects might be at least partially attributed to
patient’s expectation. Nevertheless, the observed large,
statistically significant, reduction of pain suggests a true
therapeutic effect of acupuncture, as the placebo effect
of any treatment is not likely to occur in more than 50%
of cases.
Substantial reduction of NSAID use was also evidenced
as a consequence of pain control by acupuncture: this
may be a further benefit, as NSAID side effects (25) may
be reduced. Overall costs, however, were not reduced,
due to the higher cost of acupuncture as compared
with NSAID. This confirms recent reports of a higher
cost of acupuncture as compared with conventional
treatments (26).
Our findings suggest that acupuncture may be
indicated to treat dysmenorrhea related pain, in
particular in those subjects in whom NSAID or oral
contraceptives are contraindicated or refused, pain
control being substantially higher than what
might be expected only with a placebo effect. The
definition of more precise criteria for treatment
and its modalities (e.g. duration and intensity) should
be the object of further studies allowing for a longer
follow-up.
References
1. Latthe P, Latthe M, Say L, Gulmezoglu M, Khan KS. WHO
systematic review of prevalence of chronic pelvic pain: a neglected
reproductive health morbidity. BMC Public Health 2006;6:177.
2. Harel Z. A contemporary approach to dysmenorrhea in adolescents.
Paediatr Drugs 2002;4:797–805.
3. Slap GB. Menstrual disorders in adolescence. Best Pract Res Clin
Obstet Gynecol 2003;17:75–92.
4. Durain D. Primary dysmenorrhea: assessment and management
update. J Midwifery Womens Health 2004;49:520–8.
5. Dawood MY. Dysmenorrhea. Clin Obstet Gynecol 1990;33:168–78.
6. Dawood MY. Primary dysmenorrhea: advances in phatogenesis and
management. Obstet Gynecol 2006;108:428–41.
7. Proctor M, Farquhar C. Diagnosis and management of dysmenor-
rhea. Br Med J 2006;332:1134–8.
8. Jones GL, Kennedy SH, Jenkinson C. Health related quality of life
measurement in women with common benign gynaecologic condi-
tions: a systematic review. Am J Obstet Gynecol 2002;187:501–11.
9. Deligeoroglou E, Tsimaris P, Deliveliotou A, Christopoulos P,
Creatsas G. Menstrual disorders during adolescence. Pediatr
Endocrinol Rev 2006;3: (Suppl 1): 150–9.
10. Tzafettas J. Painful menstruation. Pediatr Endocrinol Rev 2006;3:
(Suppl 1): 160–3.
11. Howard FM, Perry P, Carter J, El-Minawi AM. Pelvic Pain
Diagnosis and Management. Philadelphia: Lippincot Williams and
Wilkins, 2000, 100–7.
12. American College of Obstetricians, & Gynecologist. ACOG committee
opinion: premenstrual syndrome. Int J Gynaecol Obstet 1995;50:80–4.
13. Corney RH, Stanton R. A survey of 658 women who report
symptoms of premenstrual syndrome. J Psychosom Res 1991;35:
471–82.
14. Fugh-Berman A, Kronenberg F. Complementary and alternative
medicine (CAM) in reproductive-age women: a review of random-
ized controlled trials. Reprod Toxicol 2003;17:137–52.
15. Adams K, Assefi N. Applications of acupuncture to women’s
health. Prim Care Update Ob/Gyns 2001;8:218–25.
16. Beal MW. Acupuncture and acupressure application to women’s
reproductive health care. J Nurs Midwifery 1999;44:217–30.
17. Capodice JL, Bemis DL, Buttyan R, Kaplan SA, Katz AE.
Complementary and alternative medicine for chronic prostatitis/
chronic pelvic pain syndrome. Evid Based Complement Alternat Med
2005;2:495–501.
18. Braunstein JB, Hausfeld J, Hausfeld J, London A. Economics of
reducing menstruation with trimonthly-cycle oral contraceptive
therapy: comparison with standard-cycle regimens. Obstet Gynecol
2003;102:699–708.
19. Proctor ML, Roberts H, Farquhar CM. Combined oral contra-
ceptive pill as treatment for primary dysmenorrhea. Cochraine
Database Syst Rev 2001;4:CD002120.
20. Beijing College of Traditional Chinese Medicine. Essential of Chinese
Acupuncture. Beijing: Foreign Languages Press, 1980, 375–6.
21. Wyatt KM, Dimmock PW, Hayes-Gill B, Crowe J, O’Brien PM.
Menstrual symptometrics: a simple computer-aided method to
quantify menstrual cycle disorders. Fertil Steril 2002;78:96–101.
22. Tsenov D. The effect of acupuncture in dysmenorrhea. Akush
Ginekol (Sofia) 1996;35:24–25.
23. Helms JM. Acupuncture for the management of primary dysmenor-
rhea. Obstet Gynecol 1987;69:51–6.
24. Thomas M, Lundeberg T, Bjork G, Lundstrom-Lindstet V. Pain
and discomfort in primary dysmenorrhea is reduced by preemptive
acupuncture or low-frequency TENS. Eur J Phys Med Rehabil
1995;4:71–6.
25. Dawood MY. Dysmenorrhea. J Reprod Med 1985;30:154–67.
26. Canter PH, Thompson Coon J, Ernst E. Cost-effectiveness of
complementary therapies in the United Kingdom–a systematic
review. Evid Based Complement Alternat Med, doi:10.1093/ecam/
nel044.
Received July 24, 2006; accepted January 16, 2007
230 Acupuncture for dysmenorrhea